核黃素市場：按來源、形式、應用、地區 - 規模、份額、前景、機會分析，2022-2030

核黃素是一種維生素 B，由微生物合成。過去，它是由生產過剩率很高的微生物製成的。人體可在腸道內合成少量核黃素，但不足以滿足營養需求。它是幫助細胞生長和產生能量的輔□的組成部分之一。它還有助於脂肪、類固醇和藥物的分解。過量的膳食核黃素會從尿液中排出。

市場動態

強化食品和飲料不斷增長的需求以及核黃素的廣泛應用正在推動核黃素市場的增長。此外，越來越多地使用植物性食品和飲料也有望推動市場增長。此外，擴大在寵物食品補充劑中的使用也有望推動市場增長。

另一方面，高價格和低濕度穩定性預計將成為限制市場增長的主要因素。

本研究的主要特點

• 本報告對全球核黃素市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。
• 解釋不同細分市場的潛在收入機會，並描述該市場具有吸引力的投資建議矩陣。
• 它還提供了重要的見解，包括市場驅動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略。
• 根據公司亮點、產品組合、關鍵亮點、財務業績和戰略等參數，介紹了全球核黃素市場主要參與者的概況。
• 本研究涵蓋的主要公司包括 BASF SE、Koninklijke DSM NV、上海 Acebright Pharmaceuticals Group Co. Ltd、Xinfa Pharmaceutical Co. Ltd、湖北廣濟製藥 Co. Ltd、NB Group Co. Ltd、Hegno、Legend Industries , 和河北聖雪大成藥業有限公司。
• 此報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。看起來。
• 全球核黃素市場報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球核黃素市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場快照：按來源
  • 市場概況：按格式
  • 市場快照：按應用
  • 市場概況：按地區劃分
• 連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

• 市場動態
  • 對營養豐富的食品和飲料的需求不斷擴大
  • 核黃素對濕度和光線很敏感。
  • 對植物性食品和飲料的需求不斷擴大
• 影響分析
• 主要亮點
• 監管場景
• 產品發布和批准
• PEST 分析
• PORTER 分析
• 併購方案

第 4 章全球核黃素市場 - 冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 的流行病學特徵
• 供應方和需求方分析
• 經濟影響

第 5 章按來源分列的全球核黃素市場，2017-2030

• 化學合成
• 發酵

第 6 章按形式分列的全球核黃素市場，2017-2030

• 粉末
• 液體

第 7 章按應用分列的全球核黃素市場，2017-2030

• 食物和飲料
• 膳食補充劑
• 藥品
• 動物飼料
• 個人護理
• 其他用途

第 8 章按地區分列的全球核黃素市場，2017-2030 年

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地區

第 9 章競爭格局

• BASF SE
• Koninklijke DSM NV
• Shanghai Acebright Pharmaceuticals Group Co. Ltd
• Xinfa Pharmaceutical Co. Ltd
• Hubei Guangji Pharmaceutical Co. Ltd
• NB Group Co. Ltd
• Hegno
• Legend Industries
• Hebei Shengxue dacheng Pharmaceutical Co. Ltd

第 10 章

• 調查方法介紹
• 關於出版商

Riboflavin is a type of vitamin B. It is synthesized by microorganisms. In the past, it was made by microorganisms that had a high rate of overproduction. The human body can synthesize riboflavin in small amounts in the gut but cannot make enough to fulfill its nutritional requirements. It is one of the components of coenzymes that aid in cell growth and energy production. It also contributes to the breakdown of fats, steroids, and medications. Excess dietary riboflavin is excreted in urine.

Market Dynamics:

Growing demand from fortified food &beverage and wide-application of riboflavin are driving growth of the riboflavin market. Moreover, increasing for plant-based food and beverages is again anticipated to foster market growth. Furthermore, expanding scope in pet food supplements is further anticipated to foster market growth.

On the contrary, high price and low stability on exposure to humidity are key factors expected to restrict the market growth.

Key features of the study:

• This report provides in-depth analysis of the global riboflavin market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global riboflavin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include BASF SE, Koninklijke DSM NV, Shanghai Acebright Pharmaceuticals Group Co. Ltd, Xinfa Pharmaceutical Co. Ltd, Hubei Guangji Pharmaceutical Co. Ltd, NB Group Co. Ltd, Hegno, Legend Industries, and Hebei Shengxue dacheng Pharmaceutical Co. Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global riboflavin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global riboflavin market

Detailed Segmentation:

• Global Riboflavin Market, By Source:
  • Chemical Synthesis
  • Fermentation
• Global Riboflavin Market, By Form:
  • Powder
  • Liquid
• Global Riboflavin Market, By Application:
  • Food and Beverages
  • Dietary Supplements
  • Pharmaceutical
  • Animal Feed
  • Personal Care
  • Other Applications
• Global Riboflavin Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Source
  • Market Snapshot, By Form
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing demand from fortified food &beverages
  • Sensitivity of riboflavin toward humidity and light
  • Growing demand for plant-based food &beverages
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Riboflavin Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Riboflavin Market, By Source, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Chemical Synthesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Fermentation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Riboflavin Market, By Form, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Powder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Liquid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Riboflavin Market, By Application, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Food and Beverages
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Dietary Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Pharmaceutical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Animal Feed
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Personal Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Other Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Riboflavin Market, By Region, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2017-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

9. Competitive Landscape

• BASF SE
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Koninklijke DSM NV
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Shanghai Acebright Pharmaceuticals Group Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Xinfa Pharmaceutical Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hubei Guangji Pharmaceutical Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NB Group Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hegno
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Legend Industries
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hebei Shengxue dacheng Pharmaceutical Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us